Vaccines Market to grow at a CAGR of 4.13% by 2026, Evolving Opportunities with Johnson and Johnson & Bharat Biotech Ltd - Technavio

August 5, 2022, 11:05 AM·13 min read

NEW YORK, Aug. 5, 2022 /PRNewswire/ -- The vaccine market size is set to grow by USD 28.28 billion from 2021 to 2026, progressing at a CAGR of 4.13% according to the latest forecast report by Technavio. The vaccines market is fragmented and the vendors are deploying growth strategies such as forming strategic alliances to increase their product offerings and geographical reach to compete in the market. Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BrightPath Biotherapeutics Co. Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson, and Johnson, Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Novavax Inc., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE are some of the major market participants.

Technavio has announced its latest market research report titled Vaccines Market by Type and Geography - Forecast and Analysis 2022-2026

To know about the vendor offerings - Request a FREE sample now!

Vaccines Market 2022-2026: Scope

Our vaccines market report covers the following areas:

Vaccines Market 2022-2026: Market Dynamics

Drivers - The increased funding for vaccine development and new vaccine launches, approval of vaccines, and a strong pipeline & increasing use of adjuvants in vaccines will offer immense growth opportunities.
Challenges - High cost of vaccine research, development, and manufacturing, product recalls, and safety concerns with respect to vaccination will challenge the growth of the market participants.
For detailed information on the market dynamics - Click Now!

Vaccines Market 2022-2026: Segmentation Analysis

Type
Revenue Generating Segment -The vaccine market share growth in the prophylactic vaccines segment will be significant for revenue generation. There are different types of prophylactic vaccines, such as live attenuated vaccines, inactivated vaccines, recombinant vaccines, and toxoid vaccines.
Geography
Regional Highlights - 48% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for vaccines in North America. Market growth in this region will be slower than the growth of the market in the European and Asian regions.

To know about the market contribution of each segment -Grab an Exclusive FREE Sample Report!

Vaccines Market 2022-2026: Key Highlights

CAGR of the market during the forecast period 2022-2026
Detailed information on factors that will assist vaccines market growth during the next five years
Estimation of the vaccines market size and its contribution to the parent market
Predictions on upcoming trends and changes in consumer behavior
The growth of the vaccines market
Analysis of the market's competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of vaccines market vendors

The competitive scenario provided in the Vaccines Market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.Don't wait, Make a strategic approach & boost your business goals with our Vaccines Market Forecast Report - Buy Now!

Related Reports:

The sciatica treatment market share is expected to increase by USD 2.52 billion from 2021 to 2026, and the market's growth momentum will decelerate at a CAGR of 4.3%.
The throat cancer therapeutics market size is predicted to surge to USD 1.82 billion from 2021 to 2026 at a CAGR of 6.7%.

Vaccines Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 4.13%
Market growth 2022-2026	USD 28.28 billion
Market structure	Fragmented
YoY growth (%)	4.0
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 48%
Key consumer countries	US, Canada, Germany, UK, and France
Competitive landscape	Leading companies, competitive strategies, consumer engagement scope
Companies profiled	Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BrightPath Biotherapeutics Co. Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson, Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Novavax Inc., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE
Market Dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview	If our report has not included the data you are looking for, you can reach out to our analysts and get customized segments.

Browse for Technavio "Healthcare Market" Research Reports

Table Of Contents :

1 Executive Summary

1.1 Market overview

2 Market Landscape

2.1 Market ecosystem

3 Market Sizing

3.1 Market Definition

3.2 Market segment analysis

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021-2026

4 Five Forces Analysis

4.1 Five forces summary

4.2 Bargaining power of buyers

4.3 Bargaining power of suppliers

4.4 Threat of new entrants

4.5 Threat of substitutes

4.6 Threat of rivalry

4.7 Market condition

5 Market Segmentation by Type

5.1 Market segments

5.2 Comparison by Type

5.3 Prophylactic vaccines - Market size and forecast 2021-2026

5.4 Therapeutic vaccines - Market size and forecast 2021-2026

5.5 Market opportunity by Type

6 Customer Landscape

6.1 Customer landscape overview

7 Geographic Landscape

7.1 Geographic segmentation

7.2 Geographic comparison

7.3 North America - Market size and forecast 2021-2026

7.4 Europe - Market size and forecast 2021-2026

7.5 Asia - Market size and forecast 2021-2026

7.6 Rest of World (ROW) - Market size and forecast 2021-2026

7.7 US - Market size and forecast 2021-2026

7.8 Germany - Market size and forecast 2021-2026

7.9 UK - Market size and forecast 2021-2026

7.10 Canada - Market size and forecast 2021-2026

7.11 France - Market size and forecast 2021-2026

7.12 Market opportunity by geography

8 Drivers, Challenges, and Trends

8.1 Market drivers

8.2 Market challenges

8.3 Impact of drivers and challenges

8.4 Market trends

9 Vendor Landscape

9.1 Overview

9.2 Vendor landscape

9.3 Landscape disruption

9.4 Industry risks

10 Vendor Analysis

10.1 Vendors covered

10.2 Market positioning of vendors

10.3 Astellas Pharma Inc.

10.4 AstraZeneca Plc

10.5 Bavarian Nordic AS

10.6 Bharat Biotech Ltd.

10.7 BrightPath Biotherapeutics Co. Ltd.

10.8 CSL Ltd.

10.9 Daiichi Sankyo Co. Ltd.

10.10 Emergent BioSolutions Inc.

10.11 GlaxoSmithKline Plc

10.12 Gradalis Inc.

11 Appendix

11.1 Scope of the report

11.2 Inclusions and exclusions checklist

11.3 Currency conversion rates for US$

11.4 Research methodology

11.5 List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/vaccines-market-to-grow-at-a-cagr-of-4-13-by-2026--evolving-opportunities-with-johnson-and-johnson--bharat-biotech-ltd---technavio-301600072.html

SOURCE Technavio

Investor's Business Daily
These Semiconductor Stocks Are Likely To Benefit Most From CHIPS Act Aid
When President Joe Biden signed the CHIPS Act of 2022 into law on Aug. 9, it provided some good news for a number of chip stocks.
2d ago
TheStreet.com
Gasoline Prices Are Down, But There's a Big Threat Looming
Prices at the pump have fallen again, but the summer decline is mostly over, according to industry watchers.
12h ago
Reuters
China's July Russian coal imports hit 5-yr high as West shuns Moscow
China's coal imports from Russia jumped 14% in July from a year earlier to their highest in at least five years, as China bought discounted coal while Western countries shunned Russian cargoes over its invasion of Ukraine. China brought in 7.42 million tonnes of coal from Russia last month, data from the General Administration of Customs showed on Saturday. Western countries were avoiding cargoes from Russia ahead of a European Union ban on Russian coal that came into force on Aug. 11, aimed at reducing the Kremlin's energy revenue over its February invasion.
3h ago
Reuters
Apple supplier Foxconn to invest $300 million more in northern Vietnam - media
Apple supplier Foxconn has signed a $300 million memorandum of understanding with Vietnamese developer Kinh Bac City to expand its facility in the north of the country to diversify and boost production, state media said on Saturday. The Taiwanese company's new factory, on a plot of 50.5 hectares (125 acres) in Bac Giang province, will generate 30,000 local jobs, the Tuoi Tre newspaper said. Foxconn, formally called Hon Hai Precision Industry Co, and Kinh Bac City did not immediately respond to requests for comment.
2h ago
Yahoo Finance Video
DoorDash to end partnership with Walmart: Report
Yahoo Finance's Julie Hyman and Brian Sozzi discuss DoorDash and Walmart ending their partnership next month.
17h ago
CNW Group
Lundin Mining Provides Update on Investigations at Ojos del Salado Operation
(TSX: LUN) (Nasdaq Stockholm: LUMI) Lundin Mining Corporation ("Lundin Mining" or the "Company") continues its monitoring and technical analysis to identify the factors that led to the formation of a sinkhole near the Alcaparrosa mine at the Company's Minera Ojos del Salado operation in Chile on July 30, 2022.
1d ago
Barrons.com
Oil Prices Have Been Falling. Why It’s Time to Buy Oil Stocks.
Oil companies are minting money, and as long as crude prices don’t fall too much further, the rally should continue.
7h ago
Forkast News
Bitcoin mining difficulty rises 0.63% in latest adjustment
Bitcoin mining difficulty rose by 0.63% on Thursday, marking the second increase in a row in latest adjustments, according to data from BTC.com. See related article: Bitcoin miner Stronghold to return mining rigs to cut debt; shares plunge as losses widen Fast facts The mining difficulty reading was at 28.35 trillion, as of block height […]
1d ago
Zacks
Exxon Mobil and Nvidia have been highlighted as Zacks Bull and Bear of the Day
Exxon Mobil and Nvidia have been highlighted as Zacks Bull and Bear of the Day.
22h ago
Barrons.com
GM Reinstates Dividend but Ford’s Yield Is Higher
For advisors who invest in the auto sector: GM is going to pay investors a dividend of 9 cents a quarter. GM stock will be yielding a little less than 1%. Ford is paying investors 15 cents a quarter, or 60 cents a year, and its shares are yielding closer to 4%.
10h ago
TheStreet.com
Buffett Receives OK to More Than Double Occidental Petroleum Stake
Berkshire Hathaway plans to raise its stake in Occidental Petroleum to 50% of the company's shares.
12h ago
Insider Monkey
10 Best Self-Driving Stocks To Invest In
In this piece, we will take a look at the ten best self-driving stocks to invest in. If you want to skip our industry introduction, and want to jump ahead to the top five stocks in this list, then take a look at 5 Best Self-Driving Stocks To Invest In. The boom in information technology […]
18h ago
Insider Monkey
10 Cheap Coal Stocks to Buy Now
In this article, we discuss 10 cheap coal stocks to buy now. If you want to read about some more cheap coal stocks to buy now, go directly to 5 Cheap Coal Stocks to Buy Now. Slowing economic growth and energy market turbulence have added to the uncertainty around coal stocks in recent months, hitting […]
2d ago
MarketWatch
Diesel and natural-gas prices stay high, feeding food price inflation
Gasoline prices have been falling for weeks, but diesel and natural-gas prices remain much higher than a year ago --- raising costs for the nation’s fuel-intensive agricultural industry and leading to expectations that food prices will remain high.
17h ago
Zacks
Zacks Industry Outlook Highlights TE Connectivity, nVent Electric, TTM Technologies and CTS
TE Connectivity, nVent Electric, TTM Technologies and CTS have been highlighted in this Industry Outlook article.
2d ago
TheStreet.com
How to Invest in the Lithium That's Driving the EV Market
Perhaps most importantly, lithium has become a dominant material in the manufacturing of electric vehicles, and as millions of units are expected to be sold each year, demand for the metal may increase significantly. While it's not as valuable as precious metals like gold and silver, lithium is a sought-after metal for industrial uses. The world's biggest consumer of lithium is China, where companies use the metal to create batteries that power devices including mobile phones and scooters.
2d ago
Zacks
3 Testing Equipment Stocks to Overcome Industry Headwinds
Coronavirus-led disruptions are hurting the Zacks Electronics - Testing Equipment industry. However, industry participants like AME, FTV and NATI are set to gain from 5G prospects.
2d ago
Barrons.com
With Loan Growth Rising, This Bank Looks Like a Winner—and It Yields 3.4%
The Pittsburgh-based bank has rising earnings, a growing loan book, and the flexibility to buy back stock. Plus, it yields 3.4%.
8h ago
Zacks
Top Research Reports for Berkshire Hathaway, Airbnb & Dominion Energy
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), Airbnb, Inc. (ABNB) and Dominion Energy, Inc. (D).
12h ago
Yahoo Finance Video
Why Rivian still may not be a worthy competitor to Ford or Tesla
Yahoo Finance Live's Brian Sozzi provides his take on Rivian and why the EV maker is still not yet a competitor for Tesla or Ford.
2d ago

Recommended Stories